Impact Factor
4.02
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
5.50
1,359 total citations
h5-index
44
h5 depth signal
Cited share
81.5%
211 of 259
Total citations
1,359
Citation footprint
Metric signal
5.32
External metric anchor
Self-citation
3.5%
47 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
Japan
952
China
215
United States
119
South Korea
37
United Kingdom
22
Citing Fields of Research
Digestive Disorders
482
Hepatitis
280
Liver Diseases
235
Inflammatory Bowel Diseases & Infections
229
Liver & Colon Cancer
209
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
5,316
Articles tracked across the journal lifetime
Indexed publication set
259
211 cited publications
Last 12 months
217
18.1 publications/month
Open access share
35.0%
76 OA publications in the last year
Leading citing country
Japan
952 citing publications
Leading citing field
Digestive Disorders
482 citing publications
Latest tracked publication
6 October 2026
10 recent records available
Coverage & Indexing History
v29, 1994-
v29, 1994-
Active Coverage
Research Focus & Classification
Indexed Subjects
Digestive Disorders
Inflammatory Bowel Diseases & Infections
Hepatitis
Liver Diseases
Liver & Colon Cancer
Oncology
Issuing & Sponsoring Bodies
Contributor
Nihon Shōkakibyō Gakkai
Broad Categories
Gastroenterology
Digestive Disorders
Hepatitis
Inflammatory Bowel Diseases & Infections
Liver & Colon Cancer
MeSH Descriptors
Gastrointestinal Diseases
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1007/s00535-026-02524-z
Open DOI
Gut microbiome–enteric virus interactions: mechanisms, clinical implications, and translational directions
02
DOI 10.1007/s00535-026-02522-1
Open DOI
Healthcare burden and clinical spectrum of symptomatic polycystic liver disease in Japan: a nationwide epidemiological survey
Background: Polycystic liver disease (PLD) is often asymptomatic, but some patients develop symptoms or complications requiring care or intervention. The nationwide burden of symptomatic PLD remains poorly defined. We conducted a nationw...
03
04
05
06
DOI 10.1007/s00535-026-02506-1
Open DOI
Prior vedolizumab exposure and fibroblast-derived MMP13 are associated with ustekinumab nonresponse in ulcerative colitis
Background: As therapeutic options for ulcerative colitis increase, optimizing the sequencing of advanced therapies has become an important challenge. We examined whether baseline clinical characteristics influence the effectiveness of u...
07
08
DOI 10.1007/s00535-026-02518-x
Open DOI
The evolving landscape of chronic pancreatitis in Japan: findings from a nationwide epidemiological survey in 2021
Background: To reassess the clinico-epidemiological characteristics of chronic pancreatitis (CP) in Japan, we conducted a nationwide epidemiological survey. Methods: A two-stage nationwide survey was performed targeting patients with CP ...
09
DOI 10.1007/s00535-026-02513-2
Open DOI
A PRK-armed oncolytic adenovirus drives calreticulin exposure for dendritic cell licensing to prime antitumor CD8⁺ T cells and synergizes with anti-PD-1 or CAR-T therapy in colorectal cancer
Background: The therapeutic potential of oncolytic adenoviruses (ADVs) in colorectal cancer is constrained by a counterproductive host response: virus-triggered hyperactivation of the pro-survival AKT pathway, which fosters an immunosupp...
10
DOI 10.1007/s00535-026-02516-z
Open DOI
Young age or surgical selection? Interpreting lymph-node metastasis risk in T1 colorectal cancer
Bibliographical & Catalog Notes
Title from cover.
Also issued online.
Official publication of the Japanese Society of Gastroenterology.